Development of a 3D ex vivo model of brain-leukemia interaction to study the role of activin A in the central nervous system microenvironment

被引:0
|
作者
Erica Dander [1 ]
Francesca Pischiutta [2 ]
Noemi Di Marzo [1 ]
Rosaria Pascente [2 ]
Nicolò Panini [3 ]
Alessandra Fallati [5 ]
Andrea Biondi [1 ]
Elisa R. Zanier [1 ]
Giovanna D’Amico [4 ]
机构
[1] Fondazione IRCCS San Gerardo dei Tintori,Tettamanti Center
[2] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Departement of Acute Brain and Cardiovascular Injury
[3] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Departement of Oncology
[4] Fondazione IRCCS San Gerardo dei Tintori,Pediatrics
[5] Human Technopole,undefined
关键词
Acute lymphoblastic leukemia; Leukemia microenvironment; Organotypic brain slices; 3-dimensional model; Activin A;
D O I
10.1038/s41598-025-03877-w
中图分类号
学科分类号
摘要
B-cell type acute lymphoblastic leukemia (B-ALL) is the most common type of childhood malignancy. Although the survival rate nowadays exceeds 90%, central nervous system (CNS) involvement is associated with a poor outcome. Experimental models are needed to study the interaction between leukemia cells and the brain microenvironment to unravel new targets for drug intervention. We developed a novel three-dimensional (3D) ex vivo model utilizing murine organotypic cortical brain slices microinjected with human B-ALL cells, serving as a platform for investigating the influence of Activin A, a pro-leukemic factor, on leukemia invasion into the CNS. After injection, B-ALL cells exponentially increased in the cortical slices, promoting tissue mortality and an anti-inflammatory microenvironment phenotype, as demonstrated by morphological and gene expression alterations in microglia and astrocytes. Of note, Activin A pretreatment increased leukemia proliferation and exacerbated the effects on the microenvironment. Overall, our model presents an ideal platform for investigating the cross-talk between tumors and the brain microenvironment and the influence of disease-modifying factors. Moreover, it could facilitate drug screening across a spectrum of CNS cancers, meanwhile reducing animal usage.
引用
收藏
相关论文
empty
未找到相关数据